I'm not missing the point....I'm trying to quantify it.
There's an unknown amount of non-dilutive funding. If we knew how much the "very small, very brief Phase 1" might cost we might have a better idea of what substantially means here: "will help cover "substantially" the costs of our upcoming clinical study of oral-dosed Brilacidin",
"Fact is the non-dilutive capital is funding the oral development of B UC." I know. Substantially. But it would help to know what that means in dollars and cents and while the Company chose to keep the amount of the upfront payment to itself I thought I'd ask the poster (and any of the other people here who are familiar with the subject) how much the described trial might cost. Do you have any idea?